AdAlta Limited (1AD.AX)
| Previous Close | 0.0270 |
| Open | 0.0270 |
| Bid | 0.0260 x 25215400 |
| Ask | 0.0270 x 5549800 |
| Day's Range | 0.0260 - 0.0270 |
| 52 Week Range | 0.0170 - 0.0480 |
| Volume | |
| Avg. Volume | 2,881,950 |
| Market Cap | 13.848M |
| Beta (5Y Monthly) | 0.72 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
AdAlta to Present at August 24th Virtual Investor Summit
Melbourne, Australia--(Newsfile Corp. - August 16, 2023) - AdAlta Limited (ASX: 1AD), the clinical stage drug discovery company developing novel therapeutic products from its i-body platform, today announced that its CEO and Managing Director, Dr Tim Oldham, would be presenting at the Virtual Investor Summit on 24 August, hosted by Investor Summit Group.During his presentation at the Summit, Dr Oldham will describe the products that AdAlta is developing to treat challenging diseases such as ...
- Newsfile
AdAlta to present at June 1 Virtual Investor Summit
Melbourne, Australia--(Newsfile Corp. - May 30, 2023) - AdAlta Limited (ASX:1AD), the clinical stage drug discovery company developing novel therapeutic products from its i-body platform, today announced that its CEO and Managing Director, Dr Tim Oldham, would be presenting at the Virtual Investor Summit on 1 June, hosted by Investor Summit Group.During his presentation at the Summit, Dr Oldham will describe the products that AdAlta is developing to treat challenging diseases such as fibrosis ..
